Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Patent
1995-06-06
1997-03-25
Venkat, Jyothsna
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
424451, 424461, 424464, 424465, 424479, A61K 900
Patent
active
056141998
ABSTRACT:
Described is a new process for the preparation of alkali clavulanate from an aqueous solution of crude clavulanic acid, which is obtained in a conventional manner after the fermentation with a clavulanic-acid-producing microorganism, extracted with an ethyl acetate solution of a hydrophobic .beta.-CD derivative such as heptakis-(2,3,6-tri-O-acetyl)-.beta.-CD in at least equimolar ratio with regard to clavulanic acid. The resulting novel inclusion complexes of clavulanic acid and hydrophobic .beta.-CD derivative in a molar ratio about 1:1 are isolated, purified and then converted with an alkali base or alkali alkanoate to the desired alkali clavulanate, which is isolated. Furthermore, there are described new inclusion complexes of clavulanic acid and of its pharmaceutically acceptable alkali salts both with hydrophilic .beta.-CD derivatives and with hydrophobic .beta.-CD derivatives, processes for the preparation thereof and the use thereof for the preparation of galenic forms with immediate as well as with sustained action, in combination with amoxicillin trihydrate, which are valuable medicaments in the therapy of infectious diseases.
REFERENCES:
patent: 4454069 (1984-06-01), Cook et al.
patent: 4525353 (1985-06-01), Cole et al.
patent: 4647659 (1987-03-01), Cook et al.
patent: 4869904 (1989-09-01), Uekama et al.
patent: 5310898 (1994-05-01), Copar
Lenga, Robert, The Sigma-Aldrich Library of Chemical Safety Data, Edition 1, 1985, p. 310.
Bekers et al., Cyclodextrins in the Pharmaceutical Field, Drug Development and Industrial Pharmacy, vol. 17, No. 11 (1991) pp. 1503-1549.
Hedges, Allan, Minutes of the Sixty international Symposium on Cyclodextrins, Symposium organizezd by American Maize-Products Company (1992), pp. 1-8.
Matsubara et al., Possible Use of Triacetylated Cyclodextrins in the Preparation of Sustained-Release Oily Injection of LHRH Agonist, Buserelin Acetale, pp. 547-550.
Hendrickson et al., Organic Chemistry, 3rd Edition, (1970), pp. 1156-1157.
Szejtli, Cyclodextrin Technology, Kluwer Academic Publishers (1988), pp. 48-65.
Yamamoto et al., Some physicochemical properties of branched .beta.-cyclodextrins and their inclusion characteristics, International Journal of Pharmaceutics, vol. 49 (1989), pp. 163-171.
Catalogue Aldrich, USA.
A pamphlet by the producer of different CD derivatives Cyclolab R & D Laboratory, Budapest, Hungary.
Chemical Abstracts, The American Chemical Society, vol. 101, No. 21 (1984), p. 808.
Fercej-Temeljotov Darja
Kotnik Sonja
Kovacic Mateja
Verhnjak Katarina
Zmitek Janko
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana
Venkat Jyothsna
LandOfFree
Inclusion complexes of clavulanic acid and of alkali salts there does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inclusion complexes of clavulanic acid and of alkali salts there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inclusion complexes of clavulanic acid and of alkali salts there will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2201151